# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Katharine Hepburn (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML012-SYN-TD
- Date: 1980-05-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gwendolyn Price, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Three-month tremor review after starting propranolol and voice therapy. **S**

## History of present illness

Ms. Hepburn returns three months after her first visit and twelve weeks after starting propranolol extended-release 60 mg each morning. Her hands are steadier: she can carry a full cup again and signs letters more easily, though writing still tires her hand. The head tremor is about the same. She finished the six-week voice therapy course a month ago and uses breath support and a slightly higher pitch on stage, which steadies sustained notes. She has had no lightheadedness on standing, wheeze, cold hands, unusual tiredness, vivid dreams, or low mood, and no falls. Occupational therapy has not yet been booked. **S**

| Element | Detail |
|---|---|
| Medicine | Propranolol extended-release 60 mg daily for twelve weeks; no side effects |
| Tremor | Hands steadier; head tremor unchanged |
| Voice therapy | Six-week course completed; strategies in use |
| Falls | None |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Hand tremor better; head tremor unchanged; no stiffness or imbalance |
| Respiratory | Negative | No wheeze or breathlessness |
| Cardiovascular | Negative | No lightheadedness, fainting, or cold hands |
| Psychiatric | Negative | Mood good; sleeping well; PHQ-9 score 3 |

4 systems reviewed. **S**

## Current medications

- Propranolol extended-release 60 mg oral capsule, one capsule by mouth once daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/72 mmHg; pulse 64 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 56.4 kg; BMI 19.5 kg/m². All vital signs are synthetic.

PHQ-9: 3. All results are synthetic.

## Change since baseline

- PHQ-9: 2 at baseline, 3 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Alert and energetic |
| Cardiovascular | Regular rhythm at 64 per minute; seated blood pressure 122/72 mmHg |
| Respiratory | Clear; no wheeze |
| Neurological | TETRAS performance subscale 16, down from 22; daily-living subscale 9, down from 14. Smaller postural and kinetic hand tremor; head tremor unchanged; steadier sustained vowel. No rest tremor, bradykinesia, or rigidity |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Essential tremor** (G25.0). Hand tremor improved on propranolol, with TETRAS performance down from 22 to 16 and the daily-living score from 14 to 9. Head tremor unchanged, as is common. Pulse 64 with no side effects. The standing blood pressure was not measured today. **S**
   - Continue propranolol extended-release 60 mg each morning; no dose increase, because the pulse is 64 and she is satisfied with the benefit.
   - Seated and standing blood pressure at the six-month review.
   - Book the occupational therapy evaluation for adaptive aids.
2. **Voice tremor due to essential tremor** (R49.8). Steadier sustained notes after the voice therapy course. **S**
   - Keep using the voice strategies.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Tremor rating: TETRAS performance and activities of daily living subscales | Every visit | Completed today | Performance subscale 16, down from 22; daily-living subscale 9, down from 14 |
| Examination | Archimedes spiral drawing and handwriting sample | Every visit | Completed today | Smaller tremor waves in both spirals; handwriting steadier |
| Examination | Examination for signs beyond tremor (rest tremor, bradykinesia, rigidity, dystonia, ataxia, cognitive change) | At diagnosis, then yearly or with a change in the tremor | Up to date | No new signs; full review by neurology three months ago |
| Examination | Resting heart rate and seated and 3-minute standing blood pressure | Every visit on a beta-blocker | Deferred | Pulse 64 and seated blood pressure 122/72 mmHg were recorded, but the 3-minute standing blood pressure was not measured, a deviation from the every-visit item after starting a beta-blocker. She has no lightheadedness or falls, and the standing pressure at the six-month review showed no orthostatic drop, so no harm resulted. Corrective action: standing blood pressure is added to the rooming checklist for every visit on propranolol |
| Medication safety | Beta-blocker safety: wheeze, slow pulse or heart block, fatigue, cold hands, low mood, hypoglycemia awareness | Every visit | Completed today | No wheeze, fatigue, cold hands, or vivid dreams; pulse 64 |
| Medication safety | Primidone safety: sedation, unsteadiness, nausea | Every visit on primidone | Not indicated | Not on primidone; propranolol is working |
| Medication safety | Drugs and substances that worsen tremor (beta-agonists, valproate, lithium, antidepressants, excess thyroid hormone, caffeine) | Every visit | Completed today | No new medicines; coffee unchanged |
| Examination | Fall query, with Timed Up and Go yearly | Every visit | Completed today | No falls |
| Survey | Mood (PHQ-9) | Before a beta-blocker, after starting it, then yearly | Completed today | PHQ-9 3 after twelve weeks on propranolol; no depression |
| Laboratory | TSH and basic chemistry to exclude metabolic causes | Once at diagnosis; again only with a change in the tremor | Up to date | Normal at diagnosis; no change in the tremor to repeat them |
| Referral | Speech-language therapy for voice tremor | When voice tremor affects speech or work | Completed today | Six-week course of 12 sessions completed a month ago |
| Referral | Occupational therapy for adaptive aids | When tremor limits daily tasks | Due | Not yet booked; to be arranged now |
| Medication safety | Botulinum toxin for head or voice tremor | If head or voice tremor is disabling | Not indicated | Head tremor does not trouble her; voice steadier |
| Referral | Referral for focused ultrasound thalamotomy or deep brain stimulation | If disabling limb tremor persists after adequate trials of propranolol and primidone | Not indicated | Good response to the first medicine |
| Survey | Cognitive screen (MoCA) | Yearly | Up to date | MoCA 28 four months ago |
| Medication safety | AGS Beers Criteria medication review | Yearly from age 65 | Up to date | Reviewed three months ago; no new medicines |
| Self-management | Advance care planning and goals of care | At least yearly from 65 | Due | At the annual wellness visit in the autumn |
| Self-management | Vaccination status (influenza, pneumococcal, zoster, COVID-19, Tdap) | Yearly, per the CDC schedule | Due | At the annual wellness visit |

## Goal progress

- Less hand tremor with daily tasks on a well-tolerated medicine, with resting heart rate 55 or above and no lightheadedness, by the three-month review. Outcome by 1980-05-05: TETRAS performance subscale fell from 22 to 16 and the activities of daily living subscale from 14 to 9 on propranolol; heart rate 64; no lightheadedness or falls. **S**
- Complete a course of voice therapy and use the strategies on stage. Outcome by 1980-05-05: Six-week course completed; steadier sustained notes with breath support and a slightly higher pitch. **S**
- Use adaptive aids for eating, drinking, and writing. In progress; target 1980-10-06. **S**
- Name a health care agent and record her goals of care by the annual wellness visit. In progress; target 1980-10-06. **S**

## Guideline basis

- Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011), American Academy of Neurology (Neurology)
- Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2005), American Academy of Neurology (Neurology)
- Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018), International Parkinson and Movement Disorder Society (Movement Disorders)
- MDS evidence-based review of treatments for essential tremor (2019), International Parkinson and Movement Disorder Society (Movement Disorders)
- CMID: Clinical Monitoring Intelligence Database, general items for older adults (no essential tremor monograph) (2026), Aether Forge

## Follow-up

- Six-month tremor review in three months, with seated and standing blood pressure. Occupational therapy to be booked. **S**
- Next scheduled visit 1980-08-04: six-month tremor review. **S**
